ProteinQure

ProteinQure is a clinical-stage biotechnology company in Toronto, ON, that designs peptide therapeutics with its ProteinStudio computational platform, combining molecular simulation and AI. Its lead program, PQ203, a peptide-drug conjugate for advanced solid tumours, is in a Phase 1 trial, and it develops delivery programs for cancer, kidney and blood-brain barrier targets.